Your browser doesn't support javascript.
loading
Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes.
Brandão, Rita D; Mensaert, Klaas; López-Perolio, Irene; Tserpelis, Demis; Xenakis, Markos; Lattimore, Vanessa; Walker, Logan C; Kvist, Anders; Vega, Ana; Gutiérrez-Enríquez, Sara; Díez, Orland; de la Hoya, Miguel; Spurdle, Amanda B; De Meyer, Tim; Blok, Marinus J.
Afiliação
  • Brandão RD; Department of Clinical Genetics, Maastricht University Medical Centre+, GROW- School for Oncology and Developmental Biology, Maastricht, The Netherlands.
  • Mensaert K; Department of Data Analysis and Mathematical Modelling and Bioinformatics Institute Ghent N2N, Ghent University, Ghent, Belgium.
  • López-Perolio I; Molecular Oncology Laboratory CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
  • Tserpelis D; Department of Clinical Genetics, Maastricht University Medical Centre+, GROW- School for Oncology and Developmental Biology, Maastricht, The Netherlands.
  • Xenakis M; Department of Clinical Genetics, Maastricht University Medical Centre+, GROW- School for Oncology and Developmental Biology, Maastricht, The Netherlands.
  • Lattimore V; Department of Data Science and Knowledge Engineering, Maastricht University, Maastricht, The Netherlands.
  • Walker LC; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
  • Kvist A; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
  • Vega A; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Gutiérrez-Enríquez S; Fundación Pública Galega de Medicina Xenómica-Servicio Galgo de Saúde, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain.
  • Díez O; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • de la Hoya M; Area of Clinical and Molecular Genetics, University Hospital of Vall d'Hebron, Barcelona, Spain.
  • Spurdle AB; Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.
  • De Meyer T; Molecular Oncology Laboratory CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
  • Blok MJ; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Int J Cancer ; 145(2): 401-414, 2019 07 15.
Article em En | MEDLINE | ID: mdl-30623411
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Hereditárias sem Polipose / Splicing de RNA / Análise de Sequência de RNA / Síndrome Hereditária de Câncer de Mama e Ovário Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Hereditárias sem Polipose / Splicing de RNA / Análise de Sequência de RNA / Síndrome Hereditária de Câncer de Mama e Ovário Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article